ARCHIVES

Private Sector Still Valuable To National Cancer Program, ACS Research Chief Says

This article is from The Cancer Letter archive.

Vol. 01 No. 12 | April 26, 1974

Download PDF Visit The Full Archive

Related Articles

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

October 25, 2013

HPV Vaccine Cervarix Active In 100% Of Women In Study

July 27, 2007

Program Announcements, RFA In Radiation Effects Available

September 24, 1982

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

July 27, 2012

Waksal Pleads Guilty To Securities Fraud

October 18, 2002

NCI Programs: Institute Funds 24 DNA Microarray Centers

September 24, 1999